Ipsen is a global specialty-driven pharmaceutical group committed to discovering new solutions for targeted debilitating diseases and improving quality of life for patients. In 2016 the company struck a ground-breaking deal with Exelixis to distribute Cabozantinib in Europe. The agreement established Ipsen as a player in the highly competitive medical oncology market.
This step change for the company was the first time that Ipsen had been so deeply involved in bringing oncology drugs to market and the company needed to bring in a raft of external talent to support its ambitions. The RSA Group was tasked with filling 35 senior positions across Europe within three months. The main challenge was the client’s lack of employer branding as an oncology player. A new candidate-facing brand was needed to successfully communicate the company’s capability and ambitions in oncology and excite the small, valuable cohort of qualified candidates. A compelling narrative was needed to underpin all the individual conversations that we were going to have on their behalf.
How our approach made a difference:
The consultants began by working with the in-house team to develop a forward-looking narrative that clearly set out the company’s goals. This, combined with RSA’s global reach and extensive experience in oncology, meant we were able to screen more than 4,000 professionals across Europe and ultimately recruit 35 leaders. The roles spanned sales, marketing, medical affairs and market access functions. The whole project was completed within deadline with a median time to shortlist of 6 weeks and a median time to placement of 12 weeks with a 97% success rate.